Long-term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12-year retrospective patient analysis

被引:24
|
作者
Ziegler, S
Brunner, M
Eigenbauer, E
Minar, E
机构
[1] Univ Hosp Vienna, Sch Med, Clin Dept Internal Med 2,Div Angiol, Dept Angiol,Clin Internal Med 2, A-1090 Vienna, Austria
[2] Univ Hosp Vienna, Sch Med, Dept Clin Pharmacol, Vienna, Austria
[3] Univ Hosp Vienna, Sch Med, Inst Med Sci, Vienna, Austria
关键词
Raynaud's phenomenon; connective tissue disease; incidence of evolution; possible secondary disease;
D O I
10.1080/03009740410005007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine the frequency of development of connective tissue disease (CTD) in patients considered to have idiopathic Raynaud's phenomenon ( RP) >10 years. Patients and methods: Based on initial evaluation, 113 women and 29 men were divided into either 'primary RP' (n = 109) or 'possible secondary RP' (n = 33) groups and were re-evaluated after a median follow-up period of 12.4 years. Results: Overall 20 patients (14.1%) progressed to a definite CTD; 10 from 'primary RP' (9.2%) and 10 from 'possible secondary RP' (30.3%). Initial presence of antinuclear antibodies, thickening of fingers, higher age at onset of RP, and female sex seemed to be important determinants for a possible transition to a CTD. Conclusion: In RP-patients, who are at risk of development of a CTD, serial clinical and laboratory controls are warranted for the decision to initiate therapy early.
引用
收藏
页码:346 / 350
页数:5
相关论文
共 50 条
  • [1] Management of Raynaud's phenomenon in the patient with connective tissue disease
    Chatterjee S.
    Current Treatment Options in Cardiovascular Medicine, 2010, 12 (2) : 185 - 204
  • [2] Lingual Raynaud's phenomenon in a patient with mixed connective tissue disease
    Gilbert, Emily L.
    RHEUMATOLOGY & AUTOIMMUNITY, 2021, 1 (02): : 101 - 103
  • [3] Long-Term Outcome in Mixed Connective Tissue Disease
    Pascual, Maria
    Narvaez, Javier
    Albert Espi, Gloria
    Lopez de Recalde, Mercs
    Zacarias, Andrea
    Jose Alegre, Juan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [6] Long term iloprost therapy of severe Raynaud's phenomenon in connective tissue diseases.
    Spano, A
    Loi, G
    Bossa, RD
    Venditti, C
    Oriente, A
    Cimmino, M
    Lupo, A
    Del Puente, A
    Oriente, P
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S330 - S330
  • [7] Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease
    Di Donato, Stefano
    Huang, Suiyuan
    Pauling, John
    Del Galdo, Francesco
    Sabbagh, Maya
    Khanna, Dinesh
    Hughes, Michael
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 68
  • [8] LONG-TERM FOLLOW-UP OF 214 PRIMARY RAYNAUD' S PHENOMENON PATIENTS
    Ortiz Sanjuan, F. M.
    Alcaniz Escandell, C.
    Arevalo Ruales, K. R.
    Chalmeta Verdejo, I.
    De la Rubia Navarro, M.
    Feced Olmos, C.
    Fragio Gil, J. J.
    Gonzalez Mazario, R.
    Gonzalez Puig, L.
    Labrador Sanchez, E.
    Martinez Cordellat, I.
    Negueroles Albuixech, R.
    Grau Garcia, E.
    Ivorra Cortes, J.
    Oiler Rodriguez, J. E.
    Vicens Bernabeu, E.
    Najera Herranz, C.
    Canovas Olmos, I.
    Roman Ivorra, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1514 - 1514
  • [9] Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohort
    Landry, GJ
    Edwards, JM
    McLafferty, RB
    Taylor, LM
    Porter, JM
    JOURNAL OF VASCULAR SURGERY, 1996, 23 (01) : 76 - 86
  • [10] Long-Term Outcomes of Primary Craniofacial Reconstruction for Craniosynostosis: A 12-Year Experience
    Seruya, Mitchel
    Oh, Albert K.
    Boyajian, Michael J.
    Posnick, Jeffrey C.
    Myseros, John S.
    Yaun, Amanda L.
    Keating, Robert F.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 127 (06) : 2397 - 2406